Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Accelr8 Technology Corp.
Accelr8 Announces Study Results Projecting the Impact of Rapid Diagnosis on Choice of Initial Therapy in Serious Infections
November 21st, 2008
Accelr8 Technology Corporation (Amex: AXK) announced that research investigators at the Denver Health Medical Center presented results of a study using the company's BACcel(TM) rapid diagnostic system. They presented results of a retrospective study at the joint sessions of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC, www.icaac.org) and the Infectious Diseases Society of America (IDSA, www.idsociety.org), October 25-29 in Washington, DC. Connie S. Price, MD led the study. She is the Chief of Infectious Diseases, Denver Health, and Assistant Professor of Medicine at the University of Colorado School of Medicine. The purpose of the study was to...
Source: Health Business Week (2008-11-21)
|
